SCHEMBL5690101

SCHEMBL5690101

O=[N+]([O-])c1ccc([C@H]2CC[C@@H](NCCCc3ccccc3)CC2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 10/20 0.65
SIGMAR1 Q99720 4/20 0.51
GRIN1 Q05586 1/20 0.51
BCHE P06276 1/20 0.47
ACHE P22303 1/20 0.47
BACE1 P56817 1/20 0.47
ALDH1A1 P00352 2/20 0.46
SPHK1 Q9NYA1 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 2/20 0.46
TRPV6 Q9H1D0 1/20 0.46
MEN1 O00255 1/20 0.45
TRPA1 O75762 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
CDK2 P24941 1/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5689793 1.00 GRIN2B (0.65) GRIN2BSIGMAR1GRIN1BCHEACHE
SCHEMBL5689790 1.00 GRIN2B (0.65) GRIN2BSIGMAR1GRIN1BCHEACHE
SCHEMBL5689576 0.84 GRIN2B (0.65) GRIN2BSIGMAR1GRIN1SPHK1MEN1
SCHEMBL5689642 0.84 GRIN2B (0.65) GRIN2BSIGMAR1GRIN1SPHK1MEN1
SCHEMBL5689574 0.84 GRIN2B (0.65) GRIN2BSIGMAR1GRIN1SPHK1MEN1
SCHEMBL5689598 0.81 GRIN2B (0.57) GRIN2BSIGMAR1GRIN1SPHK1
SCHEMBL5689596 0.81 GRIN2B (0.57) GRIN2BSIGMAR1GRIN1SPHK1
SCHEMBL5689946 0.81 GRIN2B (0.61) GRIN2BSIGMAR1GRIN1SPHK1
SCHEMBL5689944 0.81 GRIN2B (0.61) GRIN2BSIGMAR1GRIN1SPHK1
SCHEMBL5690203 0.81 GRIN2B (0.61) GRIN2BSIGMAR1GRIN1SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0982026-B1 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers HOFFMANN LA ROCHE (CH) 2006-05-17 EP disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed